According to the World Health Organization (WHO), chronic lymphocytic leukemia (CLL) is a monoclonal malignancy of small and mature neoplastic B lymphocytes (CD5+) that is associated with CD19+ and CD23+ expression.1, 2, 3. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.